Renal Cancer
Multicystic Clear Cell Renal Tumors With Low-grade Nuclear Features: Time to Include TFE3 Translocation-associated Carcinomas.
November 9, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
November 8, 2023
Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology.
November 7, 2023
Renal Cell Cancer - Insights in Drug Resistance Mechanisms.
November 7, 2023
Surgical Management and Oncologic Outcomes of Renal Cell Carcinoma and Inferior Vena Caval Thrombi with Aggressive Histologic Variants.
November 7, 2023
Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review.
November 6, 2023
Regulation of HHLA2 expression in kidney cancer and myeloid cells.
November 2, 2023
The Metastasis Pattern of Renal Cell Carcinoma Is Influenced by Histologic Subtype, Grade, and Sarcomatoid Differentiation.
November 1, 2023
Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.
November 1, 2023
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis.
October 31, 2023
LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma.
October 30, 2023